Trial intelligence / Profile preview

Allopurinol in the prevention of superficial bladder tumour recurrence

2005-003219-66Phase 2Terminated

Sponsor
University Hospitals of Leicester NHS Trust
Start
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of allopurinol in bladder cancer, sponsored by University Hospitals of Leicester NHS Trust. Started Aug 2005; status: terminated.

02

Drugs

allopurinol
03

Conditions

bladder cancer

Beyond the preview

Go deeper on 2005-003219-66.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003219-66.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call